Drug
Xylometazoline Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Appendicitis | 38 | 159.4 | 171.4 | signal |
| 2 | Ventricular Fibrillation | 35 | 122.4 | 130.8 | signal |
| 3 | Cardiogenic Shock | 36 | 98.2 | 105.1 | signal |
| 4 | Incorrect Route Of Product Administration | 25 | 57.8 | 60.6 | signal |
| 5 | Ascites | 43 | 56.8 | 61.7 | signal |
| 6 | Bacterial Infection | 27 | 56.5 | 59.5 | signal |
| 7 | Multiple Organ Dysfunction Syndrome | 38 | 52.9 | 56.9 | signal |
| 8 | Neuralgia | 26 | 41.7 | 43.7 | signal |
| 9 | Hyperlipidaemia | 12 | 38.9 | 39.8 | signal |
| 10 | Toxic Epidermal Necrolysis | 15 | 38.7 | 39.7 | signal |
| 11 | Gout | 13 | 28.1 | 28.8 | signal |
| 12 | Stevens-johnson Syndrome | 16 | 27.9 | 28.7 | signal |
| 13 | Hyponatraemia | 40 | 27.7 | 29.8 | signal |
| 14 | Ulcer | 11 | 26.8 | 27.4 | signal |
| 15 | Blood Test Abnormal | 9 | 24.9 | 25.3 | signal |
| 16 | Stress | 46 | 24.8 | 27.1 | signal |
| 17 | Subarachnoid Haemorrhage | 6 | 22.8 | 23.1 | signal |
| 18 | Hernia | 11 | 22.2 | 22.6 | signal |
| 19 | Gastric Ulcer | 10 | 20.4 | 20.8 | signal |
| 20 | Blood Cholesterol Increased | 24 | 20.0 | 20.9 | signal |
| 21 | Muscle Spasticity | 6 | 18.8 | 19.0 | signal |
| 22 | Infusion Site Pain | 6 | 18.3 | 18.4 | signal |
| 23 | Chronic Obstructive Pulmonary Disease | 24 | 17.9 | 18.7 | signal |
| 24 | Eructation | 7 | 14.3 | 14.5 | signal |
| 25 | Intentional Product Misuse | 26 | 11.6 | 12.2 | signal |
| 26 | Foetal Exposure During Pregnancy | 18 | 8.6 | 8.9 | signal |
| 27 | Drug Dependence | 34 | 8.1 | 8.6 | signal |
| 28 | Needle Issue | 5 | 6.8 | 6.8 | signal |
| 29 | Intentional Self-injury | 3 | 5.8 | 5.8 | signal |
| 30 | Device Expulsion | 3 | 1.8 | 1.8 | no signal |